135 related articles for article (PubMed ID: 28184414)
1. The clinical significance of cysteine dioxygenase type 1 methylation in Barrett esophagus adenocarcinoma.
Kojima K; Yamashita K; Ushiku H; Katoh H; Ishii S; Tanaka T; Yokoi K; Suzuki M; Ooizumi Y; Igarashi K; Hosoda K; Moriya H; Mieno H; Katada N; Tanabe S; Watanabe M
Dis Esophagus; 2017 Mar; 30(3):1-9. PubMed ID: 28184414
[TBL] [Abstract][Full Text] [Related]
2. Promoter DNA methylation of CDO1 gene and its clinical significance in esophageal squamous cell carcinoma.
Ushiku H; Yamashita K; Katoh H; Ema A; Minatani N; Kikuchi M; Kojo K; Yokoi K; Tanaka T; Nishizawa N; Ishii S; Hosoda K; Moriya H; Mieno H; Katada N; Kikuchi S; Watanabe M
Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27629777
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.
Igarashi K; Yamashita K; Katoh H; Kojima K; Ooizumi Y; Nishizawa N; Nishiyama R; Kawamata H; Tajima H; Kaizu T; Kumamoto Y; Watanabe M
PLoS One; 2017; 12(11):e0188178. PubMed ID: 29161283
[TBL] [Abstract][Full Text] [Related]
4. CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients.
Meller S; Zipfel L; Gevensleben H; Dietrich J; Ellinger J; Majores M; Stein J; Sailer V; Jung M; Kristiansen G; Dietrich D
Epigenetics; 2016 Dec; 11(12):871-880. PubMed ID: 27689475
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer.
Minatani N; Waraya M; Yamashita K; Kikuchi M; Ushiku H; Kojo K; Ema A; Nishimiya H; Kosaka Y; Katoh H; Sengoku N; Tanino H; Sidransky D; Watanabe M
PLoS One; 2016; 11(1):e0144862. PubMed ID: 26785325
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of the novel tumor suppressor cysteine dioxygenase 1 in esophageal squamous cell carcinoma.
Kwon J; Park M; Kim JH; Lee HW; Kang MC; Park JH
Tumour Biol; 2015 Sep; 36(10):7449-56. PubMed ID: 25903467
[TBL] [Abstract][Full Text] [Related]
7. Differential Prognostic Relevance of Promoter DNA Methylation of
Tanaka Y; Kosaka Y; Waraya M; Yokota K; Harada H; Kaida T; Kikuchi M; Minatani N; Nishimiya H; Katoh H; Sengoku N; Watanabe M; Yamashita K
Anticancer Res; 2019 May; 39(5):2289-2298. PubMed ID: 31092420
[TBL] [Abstract][Full Text] [Related]
8. Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome.
Deckers IA; Schouten LJ; Van Neste L; van Vlodrop IJ; Soetekouw PM; Baldewijns MM; Jeschke J; Ahuja N; Herman JG; van den Brandt PA; van Engeland M
Clin Cancer Res; 2015 Aug; 21(15):3492-500. PubMed ID: 25904753
[TBL] [Abstract][Full Text] [Related]
9. HER2 expression in oesophageal carcinoma and Barrett's oesophagus associated adenocarcinoma: An Australian study.
Nagaraja V; Shaw N; Morey AL; Cox MR; Eslick GD
Eur J Surg Oncol; 2016 Jan; 42(1):140-8. PubMed ID: 26422587
[TBL] [Abstract][Full Text] [Related]
10. Cancer-specific promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene as an important prognostic biomarker of gastric cancer.
Harada H; Hosoda K; Moriya H; Mieno H; Ema A; Ushiku H; Washio M; Nishizawa N; Ishii S; Yokota K; Tanaka Y; Kaida T; Soeno T; Kosaka Y; Watanabe M; Yamashita K
PLoS One; 2019; 14(4):e0214872. PubMed ID: 30934021
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Efficacy of Postoperative Chemotherapy by DNA Methylation of CDO1 in Gastric Cancer.
Harada H; Soeno T; Yokoi K; Nishizawa N; Ushiku H; Hosoda K; Hiki N; Yamashita K
J Surg Res; 2020 Dec; 256():404-412. PubMed ID: 32777557
[TBL] [Abstract][Full Text] [Related]
12. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
[TBL] [Abstract][Full Text] [Related]
13. Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma.
Nakamoto S; Kumamoto Y; Igarashi K; Fujiyama Y; Nishizawa N; Ei S; Tajima H; Kaizu T; Watanabe M; Yamashita K
PLoS One; 2018; 13(10):e0205864. PubMed ID: 30325974
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of cancer specific methylation of the CDO1 gene in small bowel cancer.
Kojima K; Nakamura T; Ooizumi Y; Igarashi K; Tanaka T; Yokoi K; Ishii S; Nishizawa N; Katoh H; Kosaka Y; Sato T; Watanabe M; Yamashita K
PLoS One; 2019; 14(1):e0211108. PubMed ID: 30677088
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer.
Nishizawa N; Harada H; Kumamoto Y; Kaizu T; Katoh H; Tajima H; Ushiku H; Yokoi K; Igarashi K; Fujiyama Y; Okuwaki K; Iwai T; Watanabe M; Yamashita K
Cancer Sci; 2019 Sep; 110(9):2846-2855. PubMed ID: 31325200
[TBL] [Abstract][Full Text] [Related]
17. Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer.
Kojima K; Nakamura T; Ohbu M; Katoh H; Ooizumi Y; Igarashi K; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Yokota K; Kosaka Y; Sato T; Watanabe M; Yamashita K
PLoS One; 2018; 13(5):e0194785. PubMed ID: 29746493
[TBL] [Abstract][Full Text] [Related]
18. A case of early Barrett's adenocarcinoma repeatedly developing multiple metachronous lesions shortly after endoscopic therapy: an analysis for genetic and epigenetic alterations.
Watari J; Sakurai J; Morita T; Yamazaki T; Okugawa T; Toyoshima F; Tanaka J; Tomita T; Kim Y; Oshima T; Hori K; Moriichi K; Tanabe H; Fujiya M; Kohgo Y; Das KM; Matsumoto T; Miwa H
Gastrointest Endosc; 2010 Dec; 72(6):1303-7. PubMed ID: 20650453
[No Abstract] [Full Text] [Related]
19. DNA diagnosis of peritoneal fluid cytology test by CDO1 promoter DNA hypermethylation in gastric cancer.
Ushiku H; Yamashita K; Ema A; Minatani N; Kikuchi M; Kojo K; Yokoi K; Tanaka T; Nishizawa N; Ishii S; Hosoda K; Moriya H; Mieno H; Katada N; Kikuchi S; Katoh H; Watanabe M
Gastric Cancer; 2017 Sep; 20(5):784-792. PubMed ID: 28243814
[TBL] [Abstract][Full Text] [Related]
20. The prognostic impact of O6-Methylguanine-DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma.
Baumann S; Keller G; Pühringer F; Napieralski R; Feith M; Langer R; Höfler H; Stein HJ; Sarbia M
Int J Cancer; 2006 Jul; 119(2):264-8. PubMed ID: 16477636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
